Peer recovery support to help people stay on medication for opioid use disorder
Official title: Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
Run by Geisinger Clinic · NCT07197801 · Data updated 2026-11-12
This project will see if meeting with trained peer recovery supporters helps people with opioid use disorder stay on their medication treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 89 Years |
| Sex | All |
| Enrollment | 218 (estimated) |
| Sponsor | Geisinger Clinic Academic / other |
| Locations | 1 site (Danville, Pennsylvania) |
| Status | Recruiting |
| Started | December 23, 2025 |
| Main results expected | January 31, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT07197801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who started medication for opioid use disorder within the past 45 days at a Geisinger outpatient clinic and who can give informed consent and speak English are the intended participants.
✕Probably not a fit
People who are not proficient in English, who received medication for opioid use disorder at a Geisinger outpatient clinic in the 90 days before starting treatment, or who do not receive care at Geisinger clinics are not likely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare two groups of adults starting medication for opioid use disorder at a Geisinger outpatient clinic: one group offered standard care plus a peer recovery support program and one group offered standard care alone. Participants will complete a baseline questionnaire and a 6-month follow-up questionnaire and will allow researchers to access their medical records for treatment and retention data. Those in the peer-support group will be invited to meet with trained peers who have lived experience of addiction and recovery to help engagement and retention. The main outcome is retention in medication treatment over six months.
Why it matters
Potential benefit: If successful, the program could increase how long people stay on medication for opioid use disorder, which may reduce relapse and overdose risk.
How similar studies have gone: Previous peer recovery support programs have shown promising improvements in engagement and retention in addiction care, but results have been mixed and more controlled comparisons are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult ≥ 18 years of age * Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic * Willing and able to give informed consent Exclusion Criteria: * Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date * Not proficient in English
Where it's running
-
Geisinger Clinic
Danville, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Melissa Poulsen, PhD — Geisinger Clinic
- Study coordinator: Project Manager
- Email: PEERS@geisinger.edu
- Phone: 1-866-910-6486, Option 3
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
STORC: Training a support person plus patient navigation after birth
We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.
-
Personalized Addiction Treatment Enhancement for Opioid Use Disorder
A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.